Skip to content

Research at St Andrews

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

Research output: Contribution to journalArticlepeer-review

Author(s)

C R Simpson, T Shi, E Vasileiou, S V Katikireddi, S Kerr, E Moore, C McCowan, U Agrawal, S A Shah, L D Ritchie, J Murray, J Pan, D T Bradley, S J Stock, R Wood, A Chuter, J Beggs, H R Stagg, M Joy, R S M Tsang & 10 more S de Lusignan, R Hobbs, R A Lyons, F Torabi, S Bedston, M O'Leary, A Akbari, J McMenamin, C Robertson, A Sheikh

School/Research organisations

Abstract

Reports of ChAdOx1 vaccine-associated thrombocytopenia and vascular adverse events have led to some countries restricting its use. Using a national prospective cohort, we estimated associations between exposure to first-dose ChAdOx1 or BNT162b2 vaccination and hematological and vascular adverse events using a nested incident-matched case-control study and a confirmatory self-controlled case series (SCCS) analysis. An association was found between ChAdOx1 vaccination and idiopathic thrombocytopenic purpura (ITP) (0-27 d after vaccination; adjusted rate ratio (aRR) = 5.77, 95% confidence interval (CI), 2.41-13.83), with an estimated incidence of 1.13 (0.62-1.63) cases per 100,000 doses. An SCCS analysis confirmed that this was unlikely due to bias (RR = 1.98 (1.29-3.02)). There was also an increased risk for arterial thromboembolic events (aRR = 1.22, 1.12-1.34) 0-27 d after vaccination, with an SCCS RR of 0.97 (0.93-1.02). For hemorrhagic events 0-27 d after vaccination, the aRR was 1.48 (1.12-1.96), with an SCCS RR of 0.95 (0.82-1.11). A first dose of ChAdOx1 was found to be associated with small increased risks of ITP, with suggestive evidence of an increased risk of arterial thromboembolic and hemorrhagic events. The attenuation of effect found in the SCCS analysis means that there is the potential for overestimation of the reported results, which might indicate the presence of some residual confounding or confounding by indication. Public health authorities should inform their jurisdictions of these relatively small increased risks associated with ChAdOx1. No positive associations were seen between BNT162b2 and thrombocytopenic, thromboembolic and hemorrhagic events.

Close

Details

Original languageEnglish
Number of pages16
JournalNature Medicine
Early online date9 Jun 2021
DOIs
Publication statusE-pub ahead of print - 9 Jun 2021

    Research areas

  • Epidemiology, COVID-19

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study

    Simpson, C. R., Robertson, C., Vasileiou, E., Moore, E., McCowan, C., Agrawal, U., Stagg, H. R., Docherty, A., Mulholland, R., Murray, J. LK., Ritchie, L. D., McMenamin, J. & Sheikh, A., 5 Jul 2021, (E-pub ahead of print) In: The Lancet Digital Health. Online First, 9 p.

    Research output: Contribution to journalArticlepeer-review

  2. Ethnic and social inequalities in COVID-19 outcomes in Scotland: protocol for early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II)

    Henery, P., Vasileiou, E., Buchanan, D., Harrison, E., Leyland, A., Alexis, T., Robertson, C., Agrawal, U., Ritchie, L., Stock, S., McCowan, C., Docherty, A., Kerr, S., Marple, J., Wood, R., Moore, E., Simpson, C., Shiekh, A. & Katikireddi, S., 2 Jul 2021, In: BMJ Open.

    Research output: Contribution to journalArticlepeer-review

  3. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study

    Vasileiou, E., Simpson, C. R., Shi, T., Kerr, S., Agrawal, U., Akbari, A., Bedston, S., Beggs, J., Bradley, D., Chuter, A., de Lusignan, S., Docherty, A. B., Ford, D., Hobbs, FD. R., Joy, M., Katikireddi, S. V., Marple, J., McCowan, C., McGagh, D., McMenamin, J. & 12 others, Moore, E., Murray, J. LK., Pan, J., Ritchie, L., Shah, S. A., Stock, S., Torabi, F., Tsang, R. SM., Wood, R., Woolhouse, M., Robertson, C. & Sheikh, A., 1 May 2021, In: The Lancet. 397, 10285, p. 1646-1657

    Research output: Contribution to journalArticlepeer-review

  4. Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database

    Mulholland, R. H., Vasileiou, E., Simpson, C. R., Robertson, C., Ritchie, L. D., Agrawal, U., Woolhouse, M., Murray, J. L. K., Stagg, H. R., Docherty, A. B., McCowan, C., Wood, R., Stock, S. J. & Sheikh, A., 16 Apr 2021, (E-pub ahead of print) In: International Journal of Epidemiology. 11 p., dyab028.

    Research output: Contribution to journalArticlepeer-review

  5. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality

    Flook, M., Jackson, C., Vasileiou, E., Simpson, C. R., Muckian, M. D., Agrawal, U., McCowan, C., Jia, Y., Murray, J. L. K., Ritchie, L. D., Robertson, C., Stock, S. J., Wang, X., Woolhouse, M. E. J., Sheikh, A. & Stagg, H. R., 12 Apr 2021, In: BMC Infectious Diseases. 21, 23 p., 342.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries

    Solís Arce, J. S., Warren, S. S., Meriggi, N. F., Scacco, A., McMurry, N., Voors, M., Syunyaev, G., Malik, A. A., Aboutajdine, S., Adeojo, O., Anigo, D., Armand, A., Asad, S., Atyera, M., Augsburg, B., Awasthi, M., Ayesiga, G. E., Bancalari, A., Björkman Nyqvist, M., Borisova, E. & 54 others, Bosancianu, C. M., Cabra García, M. R., Cheema, A., Collins, E., Cuccaro, F., Farooqi, A. Z., Fatima, T., Fracchia, M., Galindo Soria, M. L., Guariso, A., Hasanain, A., Jaramillo, S., Kallon, S., Kamwesigye, A., Kharel, A., Kreps, S., Levine, M., Littman, R., Malik, M., Manirabaruta, G., Mfura, J. L. H., Momoh, F., Mucauque, A., Mussa, I., Nsabimana, J. A., Obara, I., Otálora, M. J., Ouédraogo, B. W., Pare, T. B., Platas, M. R., Polanco, L., Qureshi, J. A., Raheem, M., Ramakrishna, V., Rendrá, I., Shah, T., Shaked, S. E., Shapiro, J. N., Svensson, J., Tariq, A., Tchibozo, A. M., Tiwana, H. A., Trivedi, B., Vernot, C., Vicente, P. C., Weissinger, L. B., Zafar, B., Zhang, B., Karlan, D., Callen, M., Teachout, M., Humphreys, M., Mobarak, A. M. & Omer, S. B., 16 Jul 2021, (E-pub ahead of print) In: Nature Medicine. First Online, 21 p.

    Research output: Contribution to journalArticlepeer-review

  2. Deciphering the genomic, epigenomic and transcriptomic landscapes of pre-invasive lung cancer lesions

    Texeira, V. H., Pipinikas, C. P., Pennycuick, A., Lee-Six, H., Chandrasekharan, D., Beane, J., Morris, T. J., Karpathakis, A., Feber, A., Breeze, C. E., Ntolios, P., Hynds, R. E., Falzon, M., Capitanio, A., Carroll, B., Durrenberger, P. F., Hardavella, G., Brown, J. M., Lynch, A. G., Farmery, H. & 12 others, Paul, D. S., Chambers, R. C., McGranahan, N., Navani, N., Thakrar, R. M., Swanton, C., Beck, S., George, P. J., Spira, A., Campbell, P. J., Thirwell, C. & Janes, S. M., Mar 2019, In: Nature Medicine. 25, 3, p. 517-525 9 p.

    Research output: Contribution to journalArticlepeer-review

  3. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease

    Du, H., Guo, L., Fang, F., Chen, D., Sosunov, A., McKhann, G., Yan, Y., Wang, C., Zhang, H., Molkentin, J., Gunn-Moore, F. J., Vonsattel, JP., Arancio, O., Chen, JX. & Yan, SD., Oct 2008, In: Nature Medicine. 14, 10, p. 1097-1105 9 p.

    Research output: Contribution to journalArticlepeer-review

  4. Extinct 1918 virus comes alive

    Lamb, R. A. & Jackson, D., Nov 2005, In: Nature Medicine. 11, 11, p. 1154-1156 3 p.

    Research output: Contribution to journalArticlepeer-review

ID: 274690341

Top